US Patent 10065922 Solabegron zwitterion and uses thereof
Patent 10065922 was granted and assigned to Velicept Therapeutics on September, 2018 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 24, 2016
Date of Patent
September 4, 2018
Patent Applicant
Patent Application Number
15332956
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10065922 Solabegron zwitterion and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
